Vanda Pharmaceuticals reports the publication of an article recommeding its drug candidate iloperidone in Schizophrenia Research, the official journal of the Schizophrenia International Research Society,
The manuscript, entitled Common Effect of Antipsychotics on the Biosynthesis and Regulation of Fatty Acids and Cholesterol Supports a Key Role of Lipid Homeostasis in Schizophrenia, highlights the discovery of a major effect of antipsychotics that the firm says sheds new light on how the drugs work.
Vanda researchers analyzed the mechanism of action of 18 antipsychotics at the molecular level and discovered that they regulate specific genes that control the production and transport of lipids. These findings suggest that antipsychotic drugs may alter the fluidity of cell membranes of neurons, which could result in changes in neuronal connectivity.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze